Leptin Polyclonal Antibody PE-Cy7 Conjugated
Cat# MBS9462086-5x0,1mL
Size : 5x0.1mL
Brand : MyBiosource
Leptin (LEP) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9462086MBS9462086 is an antibody targeting Lep. Also known as Leptin Polyclonal Antibody PE-Cy7 Conjugated. Reactive in Mouse, Rat. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Leptin, Polyclonal Antibody
Full Product Name
Leptin Polyclonal Antibody PE-Cy7 Conjugated
Product Gene Name
anti-Lep antibody
Product Synonym Names
Leptin
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Mouse, Rat
Form/Format
0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Purity/Purification
affinity purified by Protein A
Preparation and Storage
Store at -20 degree C for one year. Avoid repeated freeze/thaw cycles.
Shipped at 4 degree C.
Shipped at 4 degree C.
Applications Tested/Suitable for anti-Lep antibody
Immunofluorescence (IF)
Application Notes for anti-Lep antibody
IF: 1:50-200
Other Notes
Small volumes of anti-Lep antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for Lep. It may not necessarily be applicable to this product.
NCBI Official Full Name
leptin
NCBI Official Synonym Full Names
leptin
NCBI Official Symbol
Lep
NCBI Official Synonym Symbols
ob; obese
UniProt Protein Name
Leptin
UniProt Synonym Protein Names
Obesity factor
Protein Family
Ethylene-responsive transcription factor
UniProt Gene Name
Lep
UniProt Synonym Gene Names
Ob
UniProt Entry Name
LEP_MOUSE
NCBI Protein Information
leptin; obesity factor
UniProt Comments for Lep
leptin: May function as part of a signaling pathway that acts to regulate the size of the body fat depot. An increase in the level of LEP may act directly or indirectly on the CNS to inhibit food intake and/or regulate energy expenditure as part of a homeostatic mechanism to maintain constancy of the adipose mass. Defects in LEP may be a cause of obesity (OBESITY). It is a condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat. Belongs to the leptin family.
Protein type: Cell development/differentiation; Secreted; Secreted, signal peptide; Hormone
Cellular Component: extracellular space; cell; cytoplasm; extracellular region; intracellular
Molecular Function: protein binding; growth factor activity; peptide hormone receptor binding; hormone activity
Biological Process: response to dietary excess; positive regulation of myeloid cell differentiation; regulation of fat cell differentiation; positive regulation of JAK-STAT cascade; regulation of steroid biosynthetic process; negative regulation of transcription from RNA polymerase II promoter; signal transduction; glucose homeostasis; negative regulation of metabolic process; negative regulation of appetite; response to insulin stimulus; positive regulation of tyrosine phosphorylation of Stat3 protein; regulation of cholesterol absorption; positive regulation of MAPKKK cascade; regulation of blood pressure; positive regulation of cell proliferation; positive regulation of ion transport; regulation of metabolic process; central nervous system neuron development; placenta development; cholesterol metabolic process; positive regulation of developmental growth; regulation of protein amino acid phosphorylation; eating behavior; bile acid metabolic process; glucose metabolic process; adult feeding behavior; fatty acid catabolic process; ovulation from ovarian follicle; leptin-mediated signaling pathway; negative regulation of vasoconstriction; tyrosine phosphorylation of STAT protein; fatty acid beta-oxidation; positive regulation of protein import into nucleus; glycerol biosynthetic process; insulin secretion; energy reserve metabolic process; hormone metabolic process; regulation of gluconeogenesis; lipid metabolic process; positive regulation of insulin receptor signaling pathway; leukocyte tethering or rolling; regulation of insulin secretion; negative regulation of apoptosis
Show more Protein type: Cell development/differentiation; Secreted; Secreted, signal peptide; Hormone
Cellular Component: extracellular space; cell; cytoplasm; extracellular region; intracellular
Molecular Function: protein binding; growth factor activity; peptide hormone receptor binding; hormone activity
Biological Process: response to dietary excess; positive regulation of myeloid cell differentiation; regulation of fat cell differentiation; positive regulation of JAK-STAT cascade; regulation of steroid biosynthetic process; negative regulation of transcription from RNA polymerase II promoter; signal transduction; glucose homeostasis; negative regulation of metabolic process; negative regulation of appetite; response to insulin stimulus; positive regulation of tyrosine phosphorylation of Stat3 protein; regulation of cholesterol absorption; positive regulation of MAPKKK cascade; regulation of blood pressure; positive regulation of cell proliferation; positive regulation of ion transport; regulation of metabolic process; central nervous system neuron development; placenta development; cholesterol metabolic process; positive regulation of developmental growth; regulation of protein amino acid phosphorylation; eating behavior; bile acid metabolic process; glucose metabolic process; adult feeding behavior; fatty acid catabolic process; ovulation from ovarian follicle; leptin-mediated signaling pathway; negative regulation of vasoconstriction; tyrosine phosphorylation of STAT protein; fatty acid beta-oxidation; positive regulation of protein import into nucleus; glycerol biosynthetic process; insulin secretion; energy reserve metabolic process; hormone metabolic process; regulation of gluconeogenesis; lipid metabolic process; positive regulation of insulin receptor signaling pathway; leukocyte tethering or rolling; regulation of insulin secretion; negative regulation of apoptosis
Research Articles on Lep
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-Lep antibody
| Reference Product | PubMed Publications |
|---|---|
| Lepr antibody | >175 publications with Lep and Lepr |
| Pparg antibody | >37 publications with Lep and Pparg |
| Tnf antibody | >28 publications with Lep and Tnf |
| Npy antibody | >22 publications with Lep and Npy |
| Stat3 antibody | >16 publications with Lep and Stat3 |
| Ghrl antibody | >11 publications with Lep and Ghrl |
| Retn antibody | >9 publications with Lep and Retn |
Pathways associated with anti-Lep antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| AMPK Signaling Pathway antibodies | AMPK Signaling Pathway Diagram |
| AMPK Signaling Pathway antibodies | AMPK Signaling Pathway Diagram |
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Adipogenesis Pathway antibodies | Adipogenesis Pathway Diagram |
| Cytokine-cytokine Receptor Interaction Pathway antibodies | Cytokine-cytokine Receptor Interaction Pathway Diagram |
| Cytokine-cytokine Receptor Interaction Pathway antibodies | Cytokine-cytokine Receptor Interaction Pathway Diagram |
| Incretin Synthesis, Secretion, And Inactivation Pathway antibodies | Incretin Synthesis, Secretion, And Inactivation Pathway Diagram |
| Jak-STAT Signaling Pathway antibodies | Jak-STAT Signaling Pathway Diagram |
| Jak-STAT Signaling Pathway antibodies | Jak-STAT Signaling Pathway Diagram |
Diseases associated with anti-Lep antibody
| Disease Name | Pubmed Publications |
|---|---|
| Obesity Antibodies | >355 publications with Lep and Obesity |
| Pain Antibodies | >174 publications with Lep and Pain |
| Insulin Resistance Antibodies | >114 publications with Lep and Insulin Resistance |
| Hyperinsulinism Antibodies | >76 publications with Lep and Hyperinsulinism |
| Weight Gain Antibodies | >60 publications with Lep and Weight Gain |
| Weight Loss Antibodies | >58 publications with Lep and Weight Loss |
| Cardiovascular Diseases Antibodies | >52 publications with Lep and Cardiovascular Diseases |
| Inflammation Antibodies | >44 publications with Lep and Inflammation |
| Fatty Liver Antibodies | >44 publications with Lep and Fatty Liver |
| Liver Diseases Antibodies | >39 publications with Lep and Liver Diseases |
Organs/Tissues associated with anti-Lep antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Brain Antibodies | >219 publications with Lep and Brain |
| Adipose Tissue Antibodies | >167 publications with Lep and Adipose Tissue |
| Skin Antibodies | >110 publications with Lep and Skin |
| Bone Marrow Antibodies | >9 publications with Lep and Bone Marrow |
| Salivary Gland Antibodies | >5 publications with Lep and Salivary Gland |
| Bladder Antibodies | >5 publications with Lep and Bladder |
| Mammary Gland Antibodies | >4 publications with Lep and Mammary Gland |
| Thymus Antibodies | >3 publications with Lep and Thymus |


